Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology 25: Signaling and Tumor Microenvironment 1

Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion

Qing Shi, Shideng Bao, Darell D. Bigner and Jeremy N. Rich
Qing Shi
Duke University Medical Center, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shideng Bao
Duke University Medical Center, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darell D. Bigner
Duke University Medical Center, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy N. Rich
Duke University Medical Center, Durham, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2006
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 47, 2006

Abstract

1683

Secreted protein acidic and rich in cysteine (SPARC) is an extracellular matrix glycoprotein overexpressed in malignant gliomas and other solid cancers. In a gene expression study, we recently demonstrated that increased SPARC expression is associated with poor prognosis in older glioblastoma patients. Forced expression of SPARC increases glioma invasion associated with increased matrix metalloproteinase expression. Also, SPARC activates the pro-survival AKT pathway to increase glioma tumor cell survival upon serum withdrawal. To determine potential SPARC signal transducers upstream of AKT, we examined the activation state of kinases that are activated in gliomas and mediate invasion. While several transmembrane growth factor receptor tyrosine kinases are not activated by SPARC, we now demonstrate that SPARC acutely activates both focal adhesion kinase (FAK) and integrin-linked kinase (ILK). SiRNA suppression of either FAK or ILK expression reduces SPARC activation of AKT with a near complete inhibition by combined targeting of FAK and ILK expression. SPARC-mediated activation of FAK and ILK contribute to the biological effects of SPARC as suppression of FAK or ILK expression attenuates the effects of SPARC on both glioma invasion and cellular survival. SPARC induces a novel interaction of ILK and FAK as both exogenous SPARC and genetic expression of SPARC induces a complex of ILK and FAK. SPARC has been linked to tumor progression in several advanced cancers. The identification of a signal transduction pathway mediating the effects of SPARC may provide a marker of tumor dependence on specific signal transduction elements.

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 66 (8 Supplement)
April 2006
Volume 66, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion
Qing Shi, Shideng Bao, Darell D. Bigner and Jeremy N. Rich
Cancer Res April 15 2006 (66) (8 Supplement) 397;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Secreted protein acidic and rich in cysteine (SPARC) activates focal adhesion kinase and integrin-linked kinase to induce AKT-dependent glioma survival and invasion
Qing Shi, Shideng Bao, Darell D. Bigner and Jeremy N. Rich
Cancer Res April 15 2006 (66) (8 Supplement) 397;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Kallikrein 14 signaling through proteinase-activated receptors
  • Pancreatic stellate cells promote malignant potential in pancreatic cancer
  • Regulation of gene expression and change of biologic characteristic in HUVEC after interaction with lung cancer cells
Show more Cellular and Molecular Biology 25: Signaling and Tumor Microenvironment 1
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement